as on December 13, 2025 at 2:29 am IST
Day's Low
Day's High
4.74%
Downside
2.77%
Upside
52 Week's Low
52 Week's High
20.95%
Downside
49.01%
Upside
Check Biocryst Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.6B
EPS (TTM)
0.3367
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-12.23
Industry PE ratio
-2.4242209631728047
PEG Ratio
-0.28
EBITDA
80.4M
Revenue (TTM)
599.8M
Profit Margin
-1.46%
Return On Equity TTM
-1925.37%
Track how Biocryst Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Biocryst Pharmaceuticals Inc in the last 5 years
Lowest (-186.63x)
June 30, 2025
Today (-12.23x)
December 13, 2025
Industry (-2.42x)
December 13, 2025
Highest (-4.77x)
December 31, 2020
Today’s Price to Earnings Ratio: -12.23x
Compare market cap, revenue, PE, and other key metrics of Biocryst Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.6B | -6.77% | -12.23 | -1.46% | |
| BUY | $22.3B | NA | 18.52 | 40.65% | |
| BUY | $15.4B | 69.38% | 37.2 | 15.95% | |
| BUY | $42.7B | NA | 21.31 | 13.81% | |
| BUY | $52.1B | -25.62% | 19.88 | 28.21% |
The Biocryst Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biocryst Pharmaceuticals Inc investment value today
Current value as on today
₹1,07,558
Returns
₹7,558
(+7.56%)
Returns from Biocryst Pharmaceuticals Inc Stock
₹797 (+0.80%)
Dollar Returns*
₹6,762 (+6.76%)
Based on 18 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 18 analysts, 83.33% of analysts recommend a 'BUY' rating for Biocryst Pharmaceuticals Inc. Average target price of $20.4
Get share price movements and forecasts by analysts on Biocryst Pharmaceuticals Inc.
What analysts predicted
62.79%UPSIDE
Target Price
$20.4
Current Price
$7.59
Analyzed by
18 Analysts
Target
$20.40
Biocryst Pharmaceuticals Inc target price $20.4, a slight upside of 62.79% compared to current price of $7.59. According to 18 analysts rating.
Search interest for Biocryst Pharmaceuticals Inc Stock has increased by 152% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:152% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -26.79M → 12.89M (in $), with an average increase of 27998.1% per quarter
Against Peers
![]()
In the last 1 year, United Therapeutics Corporation has given 36.5% return, outperforming this stock by 36.0%
Against Peers
![]()
In the last 3 years, United Therapeutics Corporation has given 78.5% return, outperforming this stock by 110.7%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 163.35M → 159.39M (in $), with an average decrease of 2.4% per quarter
Price Dip
![]()
In the last 6 months, BCRX stock has moved down by -27.0%
| Organisation | Biocryst Pharmaceuticals Inc |
| Headquarters | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
| Industry | Health Technology |
| CEO | Mr. Jon P. Stonehouse |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Jon P. Stonehouse | CEO & Executive Director |
Ms. Alane P. Barnes | Senior VP, Chief Legal Officer & Corporate Secretary |
Mr. Babar Ghias | CFO & Head of Corporate Development |
Nick Wilder | Manager of Investor Relations |
Ms. Jinky Ang Rosselli | Chief Data Innovation Officer |
Mr. Philip George | Chief Strategy Officer |
Mr. Charles K. Gayer | President & Chief Commercial Officer |
Ms. Stephanie Angelini | Chief People Officer & Chief Communications Officer |
Dr. William P. Sheridan MBBS | Chief Development Officer |
Dr. Yarlagadda S. Babu Ph.D. | Chief Discovery Officer |
Biocryst Pharmaceuticals Inc share price today is $7.59 as on at the close of the market. Biocryst Pharmaceuticals Inc share today touched a day high of $7.8 and a low of $7.23.
Biocryst Pharmaceuticals Inc share touched a 52 week high of $11.31 on and a 52 week low of $6 on . Biocryst Pharmaceuticals Inc stock price today i.e. is closed at $7.59,which is 32.89% down from its 52 week high and 26.50% up from its 52 week low.
Biocryst Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Biocryst Pharmaceuticals Inc (BCRX) shares with as little as ₹90.544 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.44 in Biocryst Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biocryst Pharmaceuticals Inc share’s latest price of $7.59 as on December 13, 2025 at 2:29 am IST, you will get 1.3175 shares of Biocryst Pharmaceuticals Inc. Learn more about
fractional shares .
Biocryst Pharmaceuticals Inc stock has given -6.77% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?